Eisai
4523.T
#2184
Rank
A$12.78 B
Marketcap
A$45.31
Share price
0.11%
Change (1 day)
-0.87%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$5.69 Billion

According to Eisai's latest financial reports the company's total liabilities are A$5.69 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31A$5.56 B11.2%
2024-03-31A$5.00 B1.36%
2023-03-31A$4.93 B-3.76%
2022-03-31A$5.12 B19.12%
2021-03-31A$4.30 B-20.99%
2020-03-31A$5.44 B2.55%
2019-03-31A$5.31 B-0.22%
2018-03-31A$5.32 B5.8%
2017-03-31A$5.03 B9.33%
2016-03-31A$4.60 B-6.88%
2015-03-31A$4.94 B6.42%
2014-03-31A$4.64 B-11.61%
2013-03-31A$5.25 B-22.22%
2012-03-31A$6.75 B-8.47%
2011-03-31A$7.38 B-6.23%
2010-03-31A$7.87 B-24.08%
2009-03-31A$10.36 B45.78%
2008-03-31A$7.11 B194.99%
2007-03-31A$2.41 B-12.07%
2006-03-31A$2.74 B12.33%
2005-03-31A$2.44 B-2.8%
2004-03-31A$2.51 B-12.29%
2003-03-31A$2.86 B9.29%
2002-03-31A$2.62 B-21.22%
2001-03-31A$3.32 B